Redeye considers Arise’s Q3 2025 report to be largely in line with estimates when adjusting for one-offs. However, there are some concerns regarding the paused revenue recognition of project Fasikan in the quarter, and we hope that there won’t be any significant negative effects going forward related to this. Arise’s management still seems optimistic to reach its implicit target of divesting >265MW in Q4 (supported by ongoing sales processes exceeding this volume), which we would consider a big catalyst for the share price.
LÄS MER
